Please login to the form below

Not currently logged in
Email:
Password:

Acetylon

This page shows the latest Acetylon news and features for those working in and with pharma, biotech and healthcare.

Celgene pays $300m upfront for immunology start-up Delinia

Celgene pays $300m upfront for immunology start-up Delinia

and autoimmune disease firm Acetylon and a $295m discovery alliance with Evotec for stem cell therapies.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2013 Pharma deals during July 2013

    Following its $15m investment in Acetylon Pharmaceuticals last year, Celgene has moved another step closer to acquiring the company. ... In addition, Acetylon shareholders could receive future milestone payments of up to $1.1bn based on regulatory ($250m)

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    110. Acetylon Pharmaceuticals / Celgene. Collaboration and option to acquire. HDAC inhibitors inc ACY-1215 for multiple myeloma (p1b).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Targovax strengthens board of directors Targovax strengthens board of directors

    Targovax strengthens board of directors. Catherine Wheeler joins from Acetylon Pharmaceutical. ... Most recently, Wheeler served Acetylon Pharmaceutical as chief medical officer and prior to that she held progressively senior clinical and business

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics